Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy

BACKGROUND: The purpose of this study was to investigate the prognostic significance of methylation of RAS association domain family protein 1 (RASSF1A) in the promoter region for patients with stage II and III colorectal cancer (CRC) receiving oxaliplatin-based chemotherapy. MATERIAL/METHODS: There...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xicai, Yuan, Wei, Hao, Furong, Zhuang, Wenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697441/
https://www.ncbi.nlm.nih.gov/pubmed/29128865
http://dx.doi.org/10.12659/MSM.903927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697441/
https://www.ncbi.nlm.nih.gov/pubmed/29128865
http://dx.doi.org/10.12659/MSM.903927

Ejemplares similares